Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.
Cselényi Z, Jönhagen ME, Forsberg A, Halldin C, Julin P, Schou M, Johnström P, Varnäs K, Svensson S, Farde L.
Cselényi Z, et al. Among authors: farde l.
J Nucl Med. 2012 Mar;53(3):415-24. doi: 10.2967/jnumed.111.094029. Epub 2012 Feb 9.
J Nucl Med. 2012.
PMID: 22323782
Free article.